Clinical Trial Update: Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update reports the completion of evaluating Erlotinib hydrochloride in combination with Quinacrine dihydrochloride for stage IIIB to st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Erlotinib hydrochloride (Erlotinib)
• Quinacrine dihydrochloride (quinacrine dihydrochloride)

Snippet

Sponsor: Neelesh Sharma MD PhD | Conditions: Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer | Phase 1 | Status: COMPLETED